Zoledronic acid
Back to search| Scientific Name: | Zoledronic acid |
| Brand Name: | Aclasta, Reclast, Zometa |
| Company Owner: | Novartis pharmaceuticals corp |
| Mechanism Of Action | Bisphosphonates are taken into the bone where they bind to hydroxyapatite. Bone resorption by osteoclasts causes local acidification, releasing the bisphosphonate, which is taken into the osteoclast by fluid-phase endocytosis. |
| Description of the Drug: | Zoledronic acid is a bisphosphonate used to treat malignancy associated hypercalcemia, multiple myeloma, and bone metastasis from solid tumors. |
| Protein Data Bank: |
|
Source: DrugBank Online – DrugBank.com. Retrieved 2023-01-23 from https://go.drugbank.com/drugs/DB00399
